Diffusion Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

CervoMed

12/08/2022 24:29

* Diffusion Pharmaceuticals Inc  DFFN.OQ  reported a
quarterly
adjusted loss of $2.06​​ per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of $2.04 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Diffusion Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of $2.06​.
    * The mean earnings estimate of analysts had fallen by
about 16.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Diffusion Pharmaceuticals Inc shares had risen by 4.8%
this
quarter and lost 54.1% so far this year.
    * The company reported a quarterly loss of $4.19 million.
    * Wall Street's median 12-month price target for Diffusion
Pharmaceuticals Inc is $40.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 11:29 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -2.04          -2.06          Missed
 Mar. 31 2022      -1.75          -2.22          Missed
 Dec. 31 2021      -2.00          -2.00          Met
 Sep. 30 2021      -2.00          -1.50          Beat